EMA — authorised 16 February 2012
- Marketing authorisation holder: GENZYME EUROPE BV
- Status: approved
🇪🇺 Caprelsa in European Union
EMA authorised Caprelsa on 16 February 2012
Marketing authorisation
Caprelsa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Caprelsa approved in European Union?
Yes. EMA authorised it on 16 February 2012.
Who is the marketing authorisation holder for Caprelsa in European Union?
GENZYME EUROPE BV holds the EU marketing authorisation.